Author:
Ton Dennis A.,van der Helm – van Mil Annette H.M.
Reference20 articles.
1. Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial;Krijbolder;Lancet,2022
2. OP0130abatacept in individuals at risk of developing rheumatoid arthritis: results from the arthritis prevention in the pre-clinical phase of RA with abatacept (APIPPRA) trial;Cope;Ann Rheum Dis,2023
3. Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial;Rech;Lancet,2024
4. Boeren A.M.P., Oei E.H.G., van der Helm-van Mil A.H.M. The value of MRI for detecting subclinical joint inflammation in clinically suspect arthralgia. RMD Open 2022;8:e002128. doi: 10.1136/rmdopen-2021-002128. PMID: 35820736; PMCID: PMC9277386.
5. Do musculoskeletal ultrasound and magnetic resonance imaging identify synovitis and tenosynovitis at the same joints and tendons? A comparative study in early inflammatory arthritis and clinically suspect arthralgia;Ohrndorf;Arthritis Res Ther,2019